Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

15018AST

Supelco

Astec® CHIROBIOTIC® V2 Chiral (5 μm) HPLC Columns

L × I.D. 10 cm × 2.1 mm, HPLC Column

Synonyme(s) :

CHIROBIOTIC V2 Chiral Chromatography Column

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Code UNSPSC :
41115700
eCl@ss :
32110501
Nomenclature NACRES :
SB.52

product name

Astec® Chirobiotic® V2 Chiral HPLC Column, 5 μm particle size, L × I.D. 10 cm × 2.1 mm

Matériaux

stainless steel column

Niveau de qualité

Agence

suitable for USP L88

Description

HPLC column

Gamme de produits

Astec®

Conditionnement

pkg of 1 ea

Fabricant/nom de marque

Astec®

Paramètres

0-45 °C temperature
241 bar pressure (3500 psi)

Technique(s)

HPLC: suitable
LC/MS: suitable

L × D.I.

10 cm × 2.1 mm

Matrice

High-purity silica gel particle platform
fully porous particle

Groupe de la matrice active

vancomycin phase

Taille des particules

5 μm

Dimension de pores

200 Å

operating pH range

3.5-7.0

Technique de séparation

chiral

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

Neutral molecules, amides, acids, esters and amines show considerable enantioselectivity on these vancomycin-based CSPs. A wide variety of secondary and tertiary amines have been separated on the CHIROBIOTIC® V in the polar ionic mode. The CHIROBIOTIC® V has demonstrated many of the separation characteristics of protein-based stationary phases, but with exceptional stability and much higher sample capacity. Some chiral analytes have been resolved that have not been reported separated on any other chiral stationary phase. CHIROBIOTIC® V and V2 differ in their bonding chemistry the pore size of the support particle, giving them different selectivity and preparative capacity.

  • Bonded phase: Vancomycin
  • Operating pH range: 3.5 - 7.0
  • Particle diameter: 5, 10 or 16 μm
  • Pore size: 100 Å (CHIROBIOTIC® V) or 200 Å (CHIROBIOTIC® V2)

CHIROBIOTIC FAQs
CHIROBIOTIC Reference Bibliography
Chiral Product Literature

Application


  • Development and validation of an UFLC-MS/MS method for enantioselectivity determination of d,l-thero-methylphenidate, d,l-thero-ethylphenidate and d,l-thero-ritalinic acid in rat plasma and its application to pharmacokinetic study.: This study highlights the application of the Astec® CHIROBIOTIC® V2 chiral HPLC column in the pharmacokinetic assessment of chiral drugs, demonstrating its utility in accurate and efficient chiral separation for analytical chemistry in pharmacological research (Zhang et al., 2016).


  • New high-performance liquid chromatography method for the determination of (R)-warfarin and (S)-warfarin using chiral separation on a glycopeptide-based stationary phase.: This paper describes a method using the Astec® CHIROBIOTIC® V2 chiral HPLC column to differentiate between the enantiomers of warfarin, showcasing its critical role in therapeutic drug monitoring and clinical pharmacology, which is essential for ensuring patient safety and efficacy in treatments (Malakova et al., 2009).

Produits recommandés

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Informations légales

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Chromatography Liquid Chiral Separations
Xiao, T.L., et al.
Encyclopedia of Separation Science, 1-15 (2000)
Enantioselective and sensitive determination of carvedilol in human plasma using chiral stationary-phase column and reverse-phase liquid chromatography with tandem mass spectrometry
Jiang, Juanjuan, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications, 960, 92-97 (2014)
Enantioselective determination of doxazosin in human plasma by liquid chromatography?tandem mass spectrometry using ovomucoid chiral stationary phase
Liu, Ke, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications, 878 (26), 2415-2420 (2010)
Quantitative determination of ondansetron in human plasma by enantioselective liquid chromatography-tandem mass spectrometry
Liu, Ke, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications, 864 (1-2), 129-136 (2008)
Validation of a chiral liquid chromatography?tandem mass spectrometry method for the determination of pantoprazole in dog plasma
Chen, Meixia, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications, 906, 85-90 (2012)

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique